ETS Boubacar Amadou Mamodou Pharmaceutical Import Profile — Niger (DGFT 2022–2026)

Name: ETS Boubacar Amadou Mamodou Pharmaceutical Import Records from India — 2 Products, $1.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

ETS Boubacar Amadou Mamodou — Pharmaceutical Importer Profile (2026) | 2 Products, $1.8M Trade | TransData Nexus

ETS Boubacar Amadou Mamodou

Pharmaceutical Importer · Niger · Respiratory & OTC Focus · $1.8M Total Trade · DGFT Verified

ETS Boubacar Amadou Mamodou is a pharmaceutical importer based in Niger with a total trade value of $1.8M across 2 products in 2 therapeutic categories. Based on 90 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. ETS Boubacar Amadou Mamodou sources from 2 verified Indian suppliers, with Socomed Pharma Private Limited accounting for 98.4% of imports.

ETS Boubacar Amadou Mamodou — Import Portfolio & Supplier Network

ETS Boubacar Amadou Mamodou import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to ETS Boubacar Amadou Mamodou?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Socomed Pharma Private Limited	$2.8M	163	98.4%
Rain Pharma Impex	$46.1K	2	1.6%

ETS Boubacar Amadou Mamodou sources from 2 verified Indian suppliers across 94 distinct formulations.

What Formulations Does ETS Boubacar Amadou Mamodou Import?

Formulation	Value	Ships
Other: new socomol (paracetamol 325 MG +diclofenac sodium 50 MG + caffeine 30 MG tablets) (pieces - packs of 20x1x10s	$111.6K	4
Other: new socomol (paracetamol 325MG+diclofenac sodium 50MG+caffeine 30MG tablets)(pieces - packs of 20x1x10s tablets)	$107.6K	3
Other: new socomol (paracetamol 325 MG +diclofenac sodium 50 MG + caffeine 30 MG tablets) (pieces - packs of 20x1x10s	$97.8K	6
Paracetamol 500 MG (pieces -packs of	$91.9K	4
Others paracetamol 325MG diclofenac sodium 50MG caffeine 30MG tablets new socomol pieces packs of 20x1x10s	$84.0K	2
Other - kwik action (paracetamol 500 MG	$80.4K	4
Other - new socomol paracetamol 325 MG+diclofenac sodium 50 MG + caffeine 30 MG tablets pieces -packs of 20 x 1 x	$74.5K	4
Other: colditabz (paracetamol 500 MG	$73.5K	3
Other - new socomol (paracetamol 325 MG	$70.9K	2
Other: kwik action (paracetamol 500 MG	$69.2K	2
Other : new socomol (paracetamol 325 MG	$68.9K	3
Other - new socomol (paracetamol 325 MG+ diclofenac sodium 50 MG + caffeine 30MG tablets) (pieces - packs of	$62.1K	3
Other - colditabz paracetamol 500 MG +caffeine 25 MG + phenylephrine hydrochloride 2.5 MG + chlorpheniramine maleate	$62.0K	3
Other: colditabz paracetamol 500 MG + caffeine 25 MG + phenylephrine hydrochloride 2.5 MG + chlorpheniramine maleate	$55.4K	2
Other: colditabz (paracetamol 500 MG + caffeine 25 MG + phenylephrine hydrochloride 2.5 MG + chlorpheniramine maleate	$53.6K	6

ETS Boubacar Amadou Mamodou imports 94 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Caffeine	Respiratory & OTC	$1.5M	69	1.4%	7
2	Chlorpheniramine	Antihistamines & Allergy	$322.1K	21	0.7%	13

ETS Boubacar Amadou Mamodou imports 2 pharmaceutical products across 2 categories into Niger totaling $1.8M.

ETS Boubacar Amadou Mamodou — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

ETS Boubacar Amadou Mamodou is a pharmaceutical importer based in Niamey, Niger, specializing in the procurement of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company plays a pivotal role in Niger's pharmaceutical distribution network, ensuring the availability of essential medications to meet the country's healthcare needs. While specific details about its parent company are not publicly available, ETS Boubacar Amadou Mamodou operates independently, focusing on sourcing and importing pharmaceutical products from international suppliers.

2Distribution Network

The company's distribution network encompasses various regions within Niger, with a primary focus on urban centers such as Niamey. While specific warehouse locations and logistics capabilities are not detailed in the available data, the company's consistent import activities suggest a well-established infrastructure capable of handling the storage and distribution of pharmaceutical products. ETS Boubacar Amadou Mamodou's geographic coverage is primarily domestic, serving the pharmaceutical needs of the Nigerien market.

3Industry Role

ETS Boubacar Amadou Mamodou functions as a primary wholesaler in Niger's pharmaceutical supply chain. By importing finished pharmaceutical formulations from international suppliers, the company bridges the gap between global manufacturers and local healthcare providers. This role is crucial in ensuring the timely availability of a diverse range of medications, thereby supporting the country's healthcare infrastructure.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — ETS Boubacar Amadou Mamodou

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with a significant majority of imports originating from a single supplier, SOCOMED PHARMA PRIVATE LIMITED. This reliance indicates a strategic partnership aimed at ensuring consistent product quality and supply reliability. However, the limited number of suppliers may pose risks related to supply chain disruptions or changes in supplier terms. The stability of this relationship is evidenced by the substantial volume of shipments and the dominance of SOCOMED PHARMA in the company's import portfolio.

2Supply Chain Resilience

The resilience of ETS Boubacar Amadou Mamodou's supply chain is closely tied to its dependence on SOCOMED PHARMA PRIVATE LIMITED. The absence of additional backup suppliers may expose the company to risks in the event of supply chain disruptions. The diversity of formulations imported, with 94 unique products, suggests a strategic approach to meeting varied market demands. However, the heavy reliance on a single supplier underscores the importance of maintaining a robust and flexible supply chain to mitigate potential risks.

3Strategic Implications

Importing Pharmaceuticals into Niger — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Niger

1Regulatory Authority & Framework

In Niger, the Ministry of Public Health is the primary regulatory authority overseeing pharmaceutical imports. Key legislation governing these imports includes the Pharmaceutical Law, which stipulates that all imports of raw materials, medicines, and packaging materials must be preceded by a declaration approved by the competent health authorities. This declaration serves as authorization for customs clearance, contingent upon the payment of applicable duties and taxes. The law also mandates that import and wholesale distribution establishments be owned or managed by licensed pharmacists, ensuring compliance with public health standards.

2Import Licensing & GMP

Importers in Niger are required to obtain authorization from the Ministry of Public Health for each importation, accompanied by analysis certificates issued by a quality control laboratory approved by the state. The recognition of Good Manufacturing Practice (GMP) certificates from reputable bodies such as the European Union (EU) GMP, World Health Organization (WHO) GMP, or Pharmaceutical Inspection Co-operation Scheme (PIC/S) is essential for ensuring product quality and regulatory compliance. Additionally, wholesale distribution authorization is mandatory for establishments involved in the importation and distribution of pharmaceutical products.

ETS Boubacar Amadou Mamodou — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

ETS Boubacar Amadou Mamodou's focus on importing products in the Respiratory & OTC and Antihistamines & Allergy therapeutic categories aligns with the prevalent health concerns in Niger. The substantial import value of caffeine-containing products indicates a significant demand for energy and alertness-enhancing medications. The inclusion of chlorpheniramine, an antihistamine, suggests a response to allergy-related health issues. This strategic product selection is driven by market demand and the company's commitment to addressing the healthcare needs of the Nigerien population.

2Sourcing Profile

ETS Boubacar Amadou Mamodou's sourcing strategy is heavily centered on generic drugs, primarily sourced from India. The company's preference for finished pharmaceutical formulations, as opposed to raw Active Pharmaceutical Ingredients (APIs) or bulk drugs, indicates a focus on ready-to-market products that can be swiftly distributed within Niger. India's established reputation for producing high-quality generic medications at competitive prices makes it a preferred sourcing destination for the company.

3Market Positioning

Seller's Guide — How to Become a Supplier to ETS Boubacar Amadou Mamodou

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Nigerien market by partnering with ETS Boubacar Amadou Mamodou. The company's concentrated sourcing pattern suggests a potential openness to diversifying its supplier base, provided that new suppliers can offer competitive pricing, reliable delivery schedules, and high-quality products. Identifying and addressing any gaps in the company's current sourcing, such as the need for additional product categories or formulations, could further enhance the attractiveness of new suppliers.

2Requirements & Qualifications

Indian exporters aiming to supply ETS Boubacar Amadou Mamodou and the Nigerien market must adhere to Niger's import regulations, including obtaining the necessary import licenses and providing analysis certificates from approved quality control laboratories. Compliance with recognized GMP standards, such as EU GMP, WHO GMP, or PIC/S, is essential to ensure product quality and facilitate smoother customs clearance processes. Additionally, exporters should ensure that their products meet Niger's labeling requirements, including French language labeling and adherence to stability and serialization mandates.

How to Approach

Frequently Asked Questions — ETS Boubacar Amadou Mamodou

What products does ETS Boubacar Amadou Mamodou import from India?

ETS Boubacar Amadou Mamodou imports 2 pharmaceutical products across 2 categories. Top imports: Caffeine ($1.5M), Chlorpheniramine ($322.1K).

Who supplies pharmaceuticals to ETS Boubacar Amadou Mamodou from India?

ETS Boubacar Amadou Mamodou sources from 2 verified Indian suppliers. The primary supplier is Socomed Pharma Private Limited (98.4% of imports, $2.8M).

What is ETS Boubacar Amadou Mamodou's total pharmaceutical import value?

ETS Boubacar Amadou Mamodou's total pharmaceutical import value from India is $1.8M, based on 90 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does ETS Boubacar Amadou Mamodou focus on?

ETS Boubacar Amadou Mamodou imports across 2 categories. The largest: Respiratory & OTC (82.3%), Antihistamines & Allergy (17.7%).

Get Full ETS Boubacar Amadou Mamodou Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.